Delivery Order HHSD200200100095I-HHSD2002001000950027

The National Institute of Allergy and Infectious Diseases awarded a $21.9 million definitive contract to MRIGlobal (doing business as Midwest Research Institute) on November 17, 2023, for the Mycobacterium Tuberculosis Quality Assessment Program. This cost-plus-fixed-fee contract, which extends through November 2030, supports NIAID clinical trials by establishing quality control and proficiency testing capabilities for tuberculosis diagnostic laboratories. MRIGlobal will operate a...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $110,000.00 firm fixed price purchase order to the National Institute for Research in Tuberculosis in India. The order is for unspecified "other functions" related to tuberculosis research. The award does not have a set-aside designation and was completed on January 27, 2014. The National Institute for Research in Tuberculosis is an international non-profit organization that has previously participated...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Akonni Biosystems Inc. The $299,976 firm fixed price contract is for the development of a "LOW COST INTEGRATED METHOD FOR ISOLATION OF M. TUBERCULOSIS DNA FROM RAW SPUTUM". The contract has a total small business set-aside designation. Akonni Biosystems is a molecular diagnostics...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $146,040.00 firm fixed-price purchase order to the National Institute For Research In Tuberculosis, a non-profit organization and hospital in India. The contract is for "EARLY BATERICIDAL ACTIVITY (EBA) OF ANTI-TB DRUGS IN INDIA." The award does not have a set-aside designation. Based on the awardee's background, it appears the National Institute For Research In Tuberculosis is providing...

This federal contract was awarded by a U.S. government agency to the National Institute For Research In Tuberculosis, a non-profit organization that operates as a hospital and conducts research on tuberculosis. The contract, valued at $100,000.00, is a purchase order that does not have a set-aside designation. The contract is for the provision of specialized medical services, facilities, staff expertise, and access to patient populations to enable research on tuberculosis treatment and disease...

This is a SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a firm fixed price of $300,000.00 and is for the development of a point-of-care test to measure antibiotic concentrations in the blood for tuberculosis (TB) treatment. Nanocomposix has prior experience providing products...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Colorado State University to conduct testing of drug combinations for Mycobacterium tuberculosis (MTB) in mice. The $1,457,348.00 contract is a delivery order under NIAID's Preclinical Services for HIV Therapeutics master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation....

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a Firm Fixed Price Delivery Order to Quest Diagnostics TB LLC, a for-profit manufacturer, for $102,346.93 to provide tuberculosis testing services, including TSPOT and IGRA testing, to support VA medical facilities. The contract is under the Medical Laboratory Testing and Analysis Services (FSS-621-II) schedule through the General Services Administration. The contract does not have...

This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Quest Diagnostics TB LLC for TSPOT tuberculosis laboratory testing services. The contract was awarded on June 6, 2019 with a potential value of $270,940.00 and a completion date of March 21, 2022. The contract was issued under the VA's Medical Laboratory Testing and Analysis Services Multiple Award Schedule (FSS-621-II). Quest Diagnostics TB LLC is a for-profit manufacturer that provides medical...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International Tuberculosis Research Center (ITRC) on August 14, 2014 for the "LTBI STUDY (2ND YEAR)" project. The contract has a ceiling value of $150,000.00 and a completion date of August 14, 2014. The contract is not designated as a set-aside. Based on the project title, this contract appears to be part of NIAID's larger efforts related to the...